AngioDynamics (ANGO) Tops Q2 EPS by 4c, Revenues Miss; Offers FY20 EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
January 7, 2020 7:00 AM ESTFiscal 2020 Second Quarter Highlights
Net sales of $70.0 million, flat compared to the prior-year quarter Gross margin increased 140 basis points year over year to 59.3% GAAP loss per share of $0.07; adjusted earnings per share of $0.06 Announces the acquisition of C3 Wave PICC tip location system subsequent to quarter end
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc.(NASDAQ: ANGO),a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and... More
